Jul 02, 2022
Half of Brits set to get Covid ‘super-booster’ vaccine designed to protect from Omicron as sub-strain cases surge
This news has been received from: the-sun.com
All trademarks, copyrights, videos, photos and logos are owned by respective news sources. News stories, videos and live streams are from trusted sources.
COVID super booster vaccines are reportedly set to get the green light for millions of Brits from autumn.
Around 30million over-50s are expected to be topped up with the jab, specifically designed to protect against the Omicron strain.2Around 30million over-50s are reportedly set to be topped up with Moderna's 'super jab' from autumnCredit: AFP
The so called super-booster from Moderna is claimed to be five times better than the original vaccine and is expected to get the go ahead from drugs regulators within weeks, the Mail on Sunday reports.
It's unofficially named "214" and uses mRNA molecules to programme the immune system to protect against two types of Covid – the original Wuhan strain and Omicron.
It comes as Omicron cases surge once again, with infection levels jumping by almost a third last week.
They still remain lower however, than peak figures from March.Read More HealthBURGER ME! Minute by minute - what eating McDonald’s does to your body in just one hour
Last Friday, the influential European Medicines Agency (EMA) said it believed Moderna’s new vaccine "may provide some advantages in widening the immune response" in recipients.
And it said "bivalent vaccines could be considered … for use as boosters".
Meanwhile, the company is already said to have held talks with UK health chiefs about dishing out the 214 jab.
Dr Paul Burton, chief medical officer at Moderna, said there is a "definite interest" from the UK in buying its new vaccine, the Telegraph reports.Most read in HealthBURGER ME! Minute by minute - what eating McDonald’s does to your body in just one hourSWELL ADVICE I'm a wellness expert – few quick tips will immediately make you less bloatedDANGEROUS SIGHTING Urgent warning after 'killer' snail is found putting 1000s in quarantineHIGH ALERT Warning to anyone attending mass gatherings this weekend over monkeypox threat
Last month, Moderna released positive results showing the so-called super jab gave strong protection against Omicron BA4 and BA5 – the two sub-variants that are driving the current wave of infection.
Dr Burton said: "I think the conclusions are that boosting … with 214, really could be a turning point in our fight against the SARS-Cov-2 virus."
It comes after survivors of the Omicron Covid wave were warned they won’t be able to fend off new strains of the bug circulating.
A study by Imperial College London found those who had previous Omicron illness were not immune to catching it again, including the older BA.1 and BA.2 versions, and newer BA.4 and BA.5 strains.
That’s despite the fact they had an immune boost against previous strains, such as Delta and Alpha.
Professor Danny Altmann, from Imperial’s Department of Immunology and Inflammation, said: “Not only can it break through vaccine defences, it looks to leave very few of the hallmarks we’d expect on the immune system.Read More on The SunPRIZE REACTION I won £14m on the lottery as a single mum - I quit work and ditched family
“It's more stealthy than previous variants and flies under the radar, so the immune system is unable to remember it.”
However, he stressed vaccines are still protective against severe disease and death.2Moderna is already said to have held talks with UK health chiefs about dishing out the 214 jabCredit: AFP
News Source: the-sun.com
Tags: eating mcdonald’s mcdonald’s designed to protect to protect against the immune system minute by minute super booster the original million over vaccines cases surge expected against the omicron new vaccine
FDA expands monkeypox vaccine authorization to increase dose supply five-fold
A health worker administers a dose of the Bavarian Nordic A/S Jynneos monkeypox vaccine at a vaccination site in West Hollywood, California, on Wednesday, Aug. 3, 2022.Jill Connelly | Bloomberg | Getty Images
The Food and Drug Administration on Tuesday expanded its authorization for the monkeypox vaccine in a way that would significantly boost the limited supply of shots.
The FDA will allow health-care providers to administer the shots through intradermal injection, which would increase the supply of doses by to fivefold. The U.S. has struggled to keep with demand for the shots as the monkeypox outbreak grows.
This is breaking news. Please check back for updates.CNBC Health & Science
Read CNBC's latest global health coverage:
- Long Covid: what we know and what we don't, according to experts
- Monkeypox: What to know about the new public health emergency, from symptoms to risk
- Biden administration declares monkeypox outbreak a public health emergency in the U.S.
- Polio found in sewage outside NYC suggesting it's spreading in the community, health officials says
- White House scrambles to play catch-up on monkeypox response
- Moderna's 2Q earnings beat expectations, but it writes off $500 million in expiring Covid shots